(Press-News.org) Imaging techniques in cancer medicine provide far more than merely information on the scale and location of cancerous ulcers. There are modern methods that additionally characterise the tumour cells precisely, for instance by specific molecules they carry on their surface. Such additional information gives doctors key clues as to the precise cancer type and enables them to predict the probability that a patient will respond to a particular form of therapy.
Positron emission tomography (PET) is one such technique. Unlike with computed tomography or magnetic resonance imaging, PET does not render the body tissue visible, but rather radioactively marked molecules – known as tracers – inside the body, which are injected into the patient's bloodstream prior to the scan. Based on the lock-and-key principle, they adhere to certain molecules on the cell surface. Through the radioactive radiation, specifically cell tissue with these surface molecules is visible on the PET scan.
Researchers from ETH Zurich, the Paul Scherrer Institute and company Merck Millipore have now developed a new tracer for PET that binds to the folic acid receptor. This receptor is interesting because it accumulates on the cell surface in many cancer types. The PET scan provides information on the size and location of the tumour and the density of the folic acid receptors on the cell surface.
World's first clinical trial
The team of researchers headed by Simon Ametamey and Roger Schibli, both professors at the Institute of Pharmaceutical Sciences at ETH Zurich, have successfully tested their new substance in mice with cervical tumours. In a next step, the scientists now want to study whether the substance proves equally successful in humans. A pilot study on patients with ovarian, lung and intestinal cancer in several Swiss hospitals, including University Hospital Zurich, is in preparation. It will be the first clinical trial on a folic acid receptor marker for PET on patients.
If the substance proves suitable, the scientists would like to use it to predict the efficacy of chemotherapy in the future. They primarily have a new generation of cancer medication in mind that also binds to the folic acid receptor, which then channels the drug into the cancer cells, where it unfolds its therapeutic effect.
Personalised medicine
"Our PET tracer provides important additional information for this targeted therapeutic approach with cytotoxic substances," says Ametamey. After all, one difficulty with the new form of therapy is that not in all patients the cancer cells carry the folic acid receptor. In the case of ovarian, cervical and brain tumours, it is nine out of ten patients, with lung cancer around three quarters and with breast cancer about half. In patients without the receptor, the novel chemotherapy is ineffective.
With the aid of the new technique, it could be possible to predict whether a patient will respond to such treatment. Patients whose tumours do not have any folic acid receptors could be spared this therapy and its side effects. Moreover, physicians can use the new PET tracer to better monitor the progress of the therapy and study whether the tumour is shrinking.
Making inflammations visible
However, the new PET tracer is not just interesting for cancer medicine, but also just the ticket for displaying inflammatory responses in the body. After all, the folic acid receptor occurs also at the surface of certain cells of the immune system, the macrophages, and only if these are in a so-called activated state during an inflammatory response. The new marker substance could thus be used to display inflammatory diseases such as arteriosclerosis, arthritis or inflammatory bowel diseases with PET.
Moreover, a third area of application is also imaginable for the substance: medication development. "If we've got a method to detect chronic inflammatory responses in a non-invasive way, we can test the efficacy of anti-inflammatory medication more effectively," explains Schibli.
Only lab in Switzerland
The work with the radioactive PET marker substance poses special challenges in terms of lab infrastructure. ETH Zurich is home to the only lab in Switzerland to possess the facilities for the development of new radioactive substances and at the same time meet the demands to produce such substances for use in clinical trials on humans. The key is to manufacture the molecules at high purity levels and in sufficient amounts. PET tracers cannot be stored since the radioactive isotope Fluorine-18 used in the study degrades rapidly (it has a half-life of less than two hours). Consequently, the researchers developed a non-radioactive precursor molecule to which they can add the radioactive Fluorine-18 at the last minute. The end product has to be transported to the patient immediately after production and quality control.
###
Literature reference
Betzel T, Müller C, Groehn V, Müller A, Reber J, Fischer CR, Krämer SD, Schibli R, Ametamey SM: Radiosynthesis and Preclinical Evaluation of 3'-Aza-2'-[18F]fluorofolic Acid: A Novel PET Radiotracer for Folate Receptor Targeting. Bioconjugate Chemistry, 2013, 24, 205-214. DOI: 10.1021/bc300483a [http://dx.doi.org/10.1021/bc300483a]
New marker substance for cancer cells
2013-07-05
ELSE PRESS RELEASES FROM THIS DATE:
Protecting drinking water systems from deliberate contamination
2013-07-05
An international project has developed a response programme for rapidly restoring the use of drinking water networks following a deliberate contamination event.
The importance of water and of water infrastructures to human health and to the running of our economy makes water systems likely targets for terrorism and CBRN (chemical, biological and radionuclide) contamination. Reducing the vulnerability of drinking water systems to deliberate attacks is one of the main security challenges.
SecurEau, a four-year Seventh Framework Programme funded project, involved 12 partners, ...
Saarland University scientists reveal structure of a supercooled liquid
2013-07-05
This news release is available in German. The experimental work, which was performed at the German Electron Synchrotron Facility (DESY) in Hamburg, involved levitating hot metal droplets and observing them as they cooled by irradiating them with x-rays from one of the world's strongest x-ray sources. The research work is funded by the German Research Foundation (DFG) and the results have just been published in 'Nature Communications'.
Supercooled liquids demonstrate some interesting phenomena when they are irradiated with an extremely bright x-ray source. Shuai ...
From manga to movies: Study offers new insights into Japan's biggest media industries
2013-07-05
Japanese films have retaken the box office in their home market in a major shift not seen since the 1960s, according to new research by the University of East Anglia (UEA).
A boom in production numbers has taken place since 2000 - in 2012 Japan produced 554 films, the first time it had broken the 500-film barrier since 1961. This is in contrast to the period from the 1950s to the end of the 1990s, when Japanese production steadily declined from about 500 movies a year to only around 250.
However, despite their popularity at home this success has yet to translate into ...
Tweet all about it -- Twitter can't replace newswires, study shows
2013-07-05
News agencies continue to have an edge over Twitter in being first with the news, a study found.
Research into reporting of news events by Twitter and newswire services has found that while Twitter can sometimes break news before newswires, for major events there is little evidence that it can replace traditional news outlets.
Twitter's main benefits for news are bringing additional coverage of events, and for sharing news items of interest to niche audiences or with a short lifespan, such as local sports results.
Scientists at the Universities of Edinburgh and Glasgow ...
Laser system allows determination of atomic binding energy of the rarest element on earth
2013-07-05
The radioactive element astatine, the name of which is derived from the Greek word for 'instability,' is so rare on earth that it has not yet been investigated to any greater extent and, as a consequence, very little is known about it. Using artificially generated astatine, the Mainz-based physicist Sebastian Rothe has now managed for the first time to experimentally explore one of its fundamental parameters, the ionization potential, and thus determine one of the most important properties of the rare element. The ionization potential is the binding energy, i.e., the amount ...
Scientists explore the mind with epigenomic maps
2013-07-05
High-resolution mapping of the epigenome has discovered unique patterns that emerge during the generation of brain circuitry in childhood.
While the 'genome' can be thought of as the instruction manual that contains the blueprints (genes) for all of the components of our cells and our body, the 'epigenome' can be thought of as an additional layer of information on top of our genes that change the way they are used.
"These new insights will provide the foundation for investigating the role the epigenome plays in learning, memory formation, brain structure and mental ...
Solitary lemurs avoid danger with a little help from the neighbors
2013-07-05
Very little is known about the Sahamalaza sportive lemur (Lepilemur sahamalazensis), other than the fact it roosts during the day in rather open situations, such as tree holes, and therefore risks falling victim to predators from both the air and the ground.
Sportive lemurs are not kept in any zoo. Prior to this research virtually nothing was known about this particular species despite the fact that it has been classified as Critically Endangered, the top threat category of the International Union for Conservation of Nature's (IUCN) Red List of Threatened Species, at ...
In subglacial lake, surprising life goes on
2013-07-05
BOWLING GREEN, O.—Lake Vostok, buried under a glacier in Antarctica, is so dark, deep and cold that scientists had considered it a possible model for other planets, a place where nothing could live.
However, work by Dr. Scott Rogers, a Bowling Green State University professor of biological sciences, and his colleagues has revealed a surprising variety of life forms living and reproducing in this most extreme of environments. A paper published June 26 in PLOS ONE (Public Library of Science - http://dx.plos.org/10.1371/journal.pone.0067221) details the thousands of species ...
Toronto team IDs proteins key in stem cell production
2013-07-05
TORONTO - A team of Toronto-based researchers may be one step closer to a 'recipe' for large-scale production of stem cells for use in research and therapy.
Induced pluripotent stem cells (iPSCs) can be of great value for medical research because they can flexibly develop into many different types of cells. However, producing these cells is challenging because the proteins that control their generation are largely unknown.
But researchers from the University of Toronto, the Hospital for Sick Children and Mount Sinai Hospital (with colleagues from the United States and ...
To feed the future, we must mine the wealth of the world's seed banks today
2013-07-05
ITHACA, N.Y. – With fewer than a dozen flowering plants out of 300,000 species accounting for 80 percent of humanity's caloric intake, people need to tap unused plants to feed the world in the near future, claims Cornell University plant geneticist Susan McCouch in the Comment feature of the July 4 issue of Nature.
To keep pace with population growth and rising incomes around the world, researchers estimate that food availability must double in the next 25 years. The biodiversity stored in plant gene banks coupled with advances in genetics and plant breeding may hold ...